State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access to Novo Nordisk (NYSE: NVO )'s Wegovy or Eli Lilly (NYSE: LLY )'s Zepbound, ...

The recent volatility in key GLP-1 stocks has put the spotlight on the anxiety Wall Street has about the weight loss market.

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr.

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The yield has risen 73.6 basis points over the past seven weeks, according to Dow Jones Market Data. On Friday, traders were ...

A registered dietitian reveals nine food that work like weight-loss drugs, helping to curb cravings and suppress your ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

So far this year, Eli Lilly (NYSE: LLY) has been on an absolute tear and is swiftly becoming the world's most prolific ...